Detalhe da pesquisa
1.
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.
Ann Hematol
; 103(1): 125-132, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37731147
2.
Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI.
Ann Hematol
; 98(3): 679-689, 2019 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-30539276
3.
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia.
Blood
; 121(19): 3843-54, S1, 2013 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-23515927
4.
Severe infections unrelated to neutropenia impact on overall survival in multiple myeloma patients: results of a single centre cohort study.
Br J Haematol
; 186(3): e13-e17, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30854624
5.
Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience.
Front Oncol
; 14: 1370405, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38680863
6.
A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.
Cancer Med
; 13(7): e7071, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38558233
7.
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience.
Leuk Res
; 114: 106803, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35150967
8.
The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients.
Dent J (Basel)
; 9(2)2021 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-33498207
9.
Corrigendum to "Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience" [Leukemia Res. 114 (March 2022) 106803].
Leuk Res
; 115: 106811, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35219543
10.
Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysis.
Blood Cancer J
; 10(2): 18, 2020 02 17.
Artigo
Inglês
| MEDLINE | ID: mdl-32066724
11.
Cytogenetic Impact on Lenalidomide Treatment in Relapsed/Refractory Multiple Myeloma: A Real-Life Evaluation.
Clin Lymphoma Myeloma Leuk
; 15(10): 592-8, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26141212